Welcome to Global Bioanalysis Summit

Global Bioanalysis Summit 2017 will be held at SanFrancisco,USA on 18-19 September 2017 with the theme “Discussing current trends and future scope in bioanalysis”. The conference organized by Clyto Access aims to bring together outstanding academic scientists, researchers and research scholars to exchange and contribute their experiences and research results on all facets of Bioanalysis. You will meet with the experts from all over the world who are working on Bioanalysis of biological samples, drugs and other metabolites of great interest. The summit is committed to providing a challenging and thought-provoking experience through engaging you in the professional theme.

Points to discuss

☛ various bioanalytical techniques
☛ metabolomics analysis, chemiluminescence sensor
☛ photoelectrochemical biosensor
☛ liquid extraction surface analysis, mass spectrometry imaging
☛ modern challenges of Bioanalysts
☛ role of bioanalysis in novel drug delivery systems

bioanalysis@clytoaccess.com

Related Topics

Biomarker assays, Metabolomics, chemiluminescence sensor, drug delivery , mass spectrometry imaging, photoelectrochemical biosensor, Small molecule bioanalysis, Large molecule bioanalysis, Environmental analysis, Food quality analysis, Forensic Bioanalysis, Drug and metabolite assays, Cell-based bioassays, Radioimmunoassays, Pharmacogenomics assays, Electrophoresis, NMR, Chromatography and separation science, Hyphenated techniques, Drug discovery, Biosensors for food safety, Microscopy, Raman Spectroscopy, Bioanalytical method validation, Trending in bioanalysis.
Abstract submission deadline (1st round)
26 May 2017
Notification of acceptance or rejection of abstract
03-10 working days from the date of submission
Final presentation should be submitted
15 days before the conference date
Early bird registration
30 May 2017

Keynote Speakers

SESSIONS

Bioanalysis is a progressive discipline for which the future holds many exciting opportunities to further reduce sample volumes, analysis cost and environmental impact, as well as to improve sensitivity, specificity, accuracy, efficiency, assay throughput, data quality, data handling and processing. 

Track 1-1: Small molecule bioanalysis

Track 1-2: Large molecule bioanalysis

Track 1-3: Elemental analysis

Track 1-4: Environmental analysis

Track 1-5: Quantitative bioanalysis

Track 1-6: Qualitative bioanalysis

Track 1-7: Food quality analysis

Track 1-8: Forensic Bioanalysis

The purpose of including bioassay in bioanalytical techniques is to compare the test substance with the International Standard preparation of the same and to find out how much test substance is required to produce the same biological effect, as produced by the standard.

Track 2-1: Biomarker assays

Track 2-2: Diagnostic assays & Test kits

Track 2-3: Drug and metabolite assays

Track 2-4: Ligand binding assays

Track 2-5: Pharmacogenomics assays

Track 2-6: Cell-based bioassays

Track 2-7: Bioassays – methods in use

Track 2-8: Radioimmunoassays

Bioanalytical techniques and methods are being used for the detection or quantitative study of human or animal biological samples. Bioanalysis  encourages the submission of articles describing forward-looking applications, including biosensors, microfluidics, miniaturized analytical devices, and new hyphenated and multi-dimensional techniques.

Track 3-1: Innovative bioanalytical methods

Track 3-2: Mass spectrometry

Track 3-3: Electrophoresis

Track 3-4: HPLC-MS/MS

Track 3-5: MS-NMR

Track 3-6: Pharmaceutical analytical techniques

Track 3-7: Chromatography and separation science

Track 3-8: Hyphenated techniques

Before a bioanalytical method can be implemented for routine use, it is widely agreed that it must first be validated to demonstrate that it is suitable for its intended purpose.

Track 4-1: Validation parameters and limitations

Track 4-2: Reference standards

Track 4-3: Analyte stability validation

Track 4-4: Regulatory and compliance issues

Track 4-5: Detector

Drug discovery and development is the process of generating compounds and evaluating all their properties to determine the feasibility of selecting one novel chemical entity (NCE) to become a safe and efficacious drug. It is widely accepted that bioanalysis is an integral part of the pharmacokinetic/pharmacodynamic characterization of an NCE.

Track 5-1: Metabolite profiling

Track 5-2: Drug design

Track 5-3: Drugs and Devices for Delivery

Track 5-4: Drug Targeting and Nanomedicines

Track 5-5: Medical Devices for Drug Delivery

Track 5-6: Drug developmental stages

Track 5-7: Drug Metabolism

Track 5-8: Market Trend and Business Development of DDS

Sometimes food items contain residues of pesticides, veterinary and human drugs, microbial toxins, preservatives, contaminants from food processing and packaging, and other residues. Novel bioanalytical methods are required for analysis of these food contaminants.

Track 6-1: Methods for pesticides determination

Track 6-2: Rapid analysis methods

Track 6-3: Food quality analysis

Track 6-4: Microbial contamination analysis

Track 6-5: Meat and pesticides testing

Track 6-6: Biosensors for food safety

Track 6-7: Analysis for Food Preservation

Automation and robotics have been effectively integrated into bioanalytical methodologies and processes to maximize sample processing throughput and the quality of data.

Track 7-1: Laboratory automation and efficiency

Track 7-2: Automated sample preparation

Track 7-3: Online and automated extraction

Track 7-4: Dried blood spot analysis

Track 7-5: Standardized kits for automated sample analysis

The general trend in bioanalytical instrumentation is the improvement of functionalities and the simultaneous shrinking in the physical size of the lab. The modern advancements aim at the bioanalytical laboratory in a box.

Track 8-1: ECL biosensor measurement

Track 8-2: Fully automated sample preparation

Track 8-3: Liquid handling robots

Track 8-4: Laboratory automation

Track 9-1: Mass spectrometer

Track 9-2: Infra-red spectra

Track 9-3: Nuclear magnetic resonance (NMR)

Track 9-4: UV-visible absorption spectra

Track 9-5: Capillary Electrophoresis

Track 9-6: Cyclic Voltammetry

Track 9-7: Microscopy

Track 9-8: Lasers

Track 9-9: Diffraction

Track 9-10: Photospectrometry

Track 9-11: Raman Spectroscopy

Track 9-12: Bioreactors

Track10-1 Parameters in environmental Analysis

Track10-2 Environmental Monitoring conditions

Track10-3 Chemical Oxygen Cycle

Track10-4 Biological Cycle

Track10-5 Volatile Organic Compounds Analysis

Track10-6 Air Quality Analysis

Track10-7 Soil Testing

Track10-8 Water Quality Testing

Track10-9 Waste Management Analysis

Track10-10 Pollution Control

What is Bioanalysis 2017?

Global Bioanalysis Summit 2017 is a two- day conference designed to encourage researchers in the field of bioanalysis and to explore the new analytical platforms to challenge future, providing opportunity to learn about advances in technology, new approaches to bioassays and bioanalytical techniques development. We request all the professionals and industrialists working in the field of bioanalysis and bioanalytical techniques development to come together, to share their best practices for analysis of biological samples and to discuss the novel methods for analyzing the biological samples, to participate and share experiences to the global researchers.

Who to attend Bioanalysis 2017 ?

Global Bioanalysis Summit 2017 is providing a platform to discuss scientific and methodological applications associated with the analysts and scientist who are working in the field of bioanalysis to support drug discovery and all phases of drug development. This summit will be of interest to professionals like analytical academic scientists, analysts and research scholars, directors and professors from Universities/ Institutions, application specialists, chemists, investigators, Post-doctoral and PhD students working on analytical method improvement, analytical specialists in pharmaceutical, life sciences, health care industry.

Why to attend Bioanalysis 2017 ?

Bioanalysis 2017 provides the bioanalyst with a forum for sharing the original research on: Analyte extraction and sample preparation, Biomarker assays, Chromatography and separation sciences, Diagnostic assays and test kits, Drug and metabolite assays, Innovative bioanalytical methods, Mass spectrometry and other key detection methods, New instrumentation and equipment, Pharmacogenomics assays to the other participants.

MARKET ANALYSIS


The biologics market is estimated to be approximately $190-200 billion by 2015 with a growth rate of 9.9% from 2010. Increased share of large molecule in Pharma R&D pipeline have increased the demand for more Bioanalytical testing. In this scenario, Pharma companies are increasingly adopting outsourcing (from 26% of Bioanalytical spending in 2011-2012 to 36% in 2012-2013) as a strategy to contain cost, reduce time and access expertise. The growth in small molecule NCEs (New Chemical Entity) has been less than 1% per annum in contrast to that of large molecule NBE (New Biological Entity) which is about 25% from 2000 to 2010. Furthermore the sale of the small molecules is growing at a CAGR of 3.9% and that of large molecules at a CAGR of 10.1% from 2009 to 2015. The global advanced drug delivery market should grow from roughly $178.8 billion in 2015 to nearly $227.3 billion by 2020, with a compound annual growth rate (CAGR) of 4.9%. The global pharmaceutical market is expected to surpass US$400 bn by 2018. The development of biopharmaceuticals represents a milestone for the industry and personalized therapies carry immense promise in the near future.

CONFERENCE HIGHLIGHTS


The open panel discussion intend to have solemn discussion involving current challenges in the area of bioanalysis in which all attendees can interact with the panel followed by a Q/A session.
The attendees can interact with each other and exchange ideas that can be of great help to someone conducting analogous research.
Keynote speakers and speakers would share their expertise and their current research work. The students (Ph.D. and Post Doc. Fellows) can present their posters.
Industry professionals and academic professionals delivering a workshop on various methods and techniques, with interactive Q&A session.

Organizing Committee

Our Speakers

Programs Programs Detail Time
1

SPOT REGISTRATIONS

08:00 AM
2

INAUGURATION OF GLOBAL BIOANALYSIS SUMMIT 2017

09:00 AM
3

KEYNOTE SESSIONS #1

09:30 AM
4

REFRESHMENTS BREAK

10:30 AM
5

KEYNOTE SESSIONS #2

11:00 AM
6

REFRESHMENTS - LUNCH BREAK

12:30 PM
7

SCIENTIFIC SESSIONS - SPEECH OPPORTUNITY AVAILABLE

01:30 PM
8

SCIENTIFIC SESSIONS - SPEECH OPPORTUNITY AVAILABLE

03:30 PM
9

DAY #1 - CLOSURE

06:00 PM

venue

TBD

address

TBD


Reach Us at


Clyto Access (USA)
  • 600 West Broadway Suite 700
  • San Diego CA 92101 | USA
  • Phone: 1-619-471-1648

Clyto Access (India)
  • Novel Business Center
  • 10 BTM Layout 1 | Bengaluru,
  • Karnataka 560068 | India
  • Phone: 91-080-41474547

www.clytoaccess.com
contact@clytoaccess.com
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright © Clytoaccess 2017